Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A14500 | 29379801 | J Diabetes Res | Quercetin Improves Glucose and Lipid Metabolism of Diabetic Rats: Involvement of Akt Signaling and SIRT1. | 2017 | Details |
| A14501 | 29379590 | Gastroenterol Hepatol Bed Bench | The effect of telenursing on self-efficacy in patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial. | 2017 | Details |
| A14502 | 29379536 | Arch Med Sci | Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players? | 2016 | Details |
| A14503 | 29378307 | Clin Gastroenterol Hepatol | Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis. | 2018 | Details |
| A14504 | 29378152 | Can J Physiol Pharmacol | Beneficial effects of N-acetylcysteine on hepatic oxidative stress in streptozotocin-induced diabetic rats. | 2018 | Details |
| A14505 | 29377504 | Liver Int | A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study. | 2018 | Details |
| A14506 | 29377462 | Liver Int | Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib. | 2018 | Details |
| A14508 | 29377201 | Ann N Y Acad Sci | Cardiometabolic risk in obese children. | 2018 | Details |
| A14509 | 29376983 | Zh Nevrol Psikhiatr Im S S Korsakova | [Antiinflammatory treatment in patients with chronic back pain]. | 2019 | Details |
| A14510 | 29376471 | Adipocyte | Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization. | 2018 | Details |
| A14512 | 29375205 | World J Gastroenterol | INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis. | 2018 | Details |
| A14513 | 29375204 | World J Gastroenterol | Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis. | 2018 | Details |
| A14514 | 29373238 | Dig Liver Dis | Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease. | 2017 | Details |
| A14516 | 29373070 | J Med Food | Lipolysis-Stimulating Peptide from Soybean Protects Against High Fat Diet-Induced Apoptosis in Skeletal Muscles. | 2018 | Details |
| A14517 | 29372507 | Hepatol Int | Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A14518 | 29371998 | Toxicol Res | Protective Effect of Isoliquiritigenin against Ethanol-Induced Hepatic Steatosis by Regulating the SIRT1-AMPK Pathway. | 2018 | Details |
| A14519 | 29371918 | Oncotarget | Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesis. | 2017 | Details |
| A14520 | 29371773 | Indian J Clin Biochem | The Effects of Onion Consumption on Prevention of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14521 | 29369303 | AIDS Rev | Report from the International Conference on Viral Hepatitis - 2017. | 2018 | Details |
| A14523 | 29368124 | Dig Dis Sci | Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14524 | 29367738 | Cell Death Dis | Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease. | 2018 | Details |
| A14525 | 29367725 | Sci Rep | Omentectomy Prevents Metabolic Syndrome By Reducing Appetite and Body Weight In A Diet-Induced Obesity Rat Model. | 2018 | Details |
| A14526 | 29367619 | Cell Death Dis | Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease. | 2018 | Details |
| A14527 | 29367486 | J Oleo Sci | Improvement of Diet-induced Obesity by Ingestion of Mushroom Chitosan Prepared from Flammulina velutipes. | 2018 | Details |
| A14528 | 29367468 | JCI Insight | DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis. | 2018 | Details |
| A14529 | 29367207 | Gut | Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation. | 2018 | Details |
| A14531 | 29366871 | Food Chem Toxicol | Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice. | 2018 | Details |
| A14533 | 29366420 | Curr Pediatr Rev | Predictors of Non-Alcoholic Liver Disease in Ethnically Diverse Overweight Children and Adolescents. | 2018 | Details |
| A14534 | 29364302 | Food Funct | Effects of a combined intervention with a lentil protein hydrolysate and a mixed training protocol on the lipid metabolism and hepatic markers of NAFLD in Zucker rats. | 2018 | Details |
| A14535 | 29364093 | Acta Gastroenterol Belg | The role of insulin - like growth factor - 1 on steatohepatitis. | 2018 | Details |
| A14536 | 29364090 | Acta Gastroenterol Belg | Serum concentrations of Cyclophilin A in patients with Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14537 | 29363914 | Pol J Pathol | Expression of resistin in the liver of patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A14538 | 29363154 | J Ultrasound Med | Nonalcoholic Fatty Liver Is Associated With Further Left Ventricular Abnormalities in Patients With Type 2 Diabetes Mellitus: A 3-Dimensional Speckle-Tracking Study. | 2018 | Details |
| A14539 | 29363040 | Drugs | Semaglutide: First Global Approval. | 2018 | Details |
| A14540 | 29362454 | Sci Rep | Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance. | 2018 | Details |
| A14541 | 29361497 | Mol Metab | Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR. | 2018 | Details |
| A14542 | 29361464 | Cell Syst | Integration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A14543 | 29360762 | Mar Drugs | Protective Effect of Meretrix meretrix Oligopeptides on High-Fat-Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice. | 2018 | Details |
| A14546 | 29359590 | Arch Physiol Biochem | Association of carotid intima media thickness with atherogenic index of plasma, apo B/apo A-I ratio and paraoxonase activity in patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A14547 | 29359454 | J Ultrasound Med | Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14548 | 29359396 | Liver Int | Association between cotinine-verified smoking status and risk of nonalcoholic fatty liver disease. | 2018 | Details |
| A14549 | 29359341 | Aliment Pharmacol Ther | Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients. | 2018 | Details |
| A14550 | 29358945 | PPAR Res | Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14551 | 29358469 | Diabetes Care | Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis. | 2018 | Details |
| A14552 | 29357809 | Cardiovasc Hematol Agents Med Chem | Coagonist of GLP-1 and Glucagon Receptor Ameliorates Development of Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A14553 | 29357123 | Compr Physiol | Triglyceride Metabolism in the Liver. | 2017 | Details |
| A14554 | 29356764 | J Pediatr Gastroenterol Nutr | Pediatric Nonalcoholic Fatty Liver Disease: Current Thinking. | 2018 | Details |
| A14555 | 29356708 | Curr Opin Organ Transplant | Nonalcoholic steatohepatitis: the new frontier for liver transplantation. | 2018 | Details |
| A14556 | 29356032 | Hepatology | Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials. | 2018 | Details |
| A14557 | 29355950 | J Pharm Pharmacol | Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats. | 2018 | Details |
| A14558 | 29355688 | Toxicol Lett | Metabolomics profiling of steatosis progression in HepaRG® cells using sodium valproate. | 2018 | Details |
| A14559 | 29354946 | Zhongguo Zhen Jiu | [Mechanisms of acupuncture for non-alcoholic fatty liver disease: researches progress and prospects]. | 2018 | Details |
| A14561 | 29353414 | Probiotics Antimicrob Proteins | Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats. | 2019 | Details |
| A14563 | 29353208 | Biomed Pharmacother | Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin. | 2018 | Details |
| A14564 | 29351486 | Am J Physiol Endocrinol Metab | Different physiological roles of insulin receptors in mediating nutrient metabolism in zebrafish. | 2017 | Details |
| A14565 | 29351427 | Am J Physiol Regul Integr Comp Physiol | Role of PTP1B in POMC neurons during chronic high-fat diet: sex differences in regulation of liver lipids and glucose tolerance. | 2017 | Details |
| A14566 | 29351115 | Eur J Gastroenterol Hepatol | Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis. | 2018 | Details |
| A14567 | 29350757 | J Food Sci | Hepatoprotective Effects of Sophoricoside against Fructose-Induced Liver Injury via Regulating Lipid Metabolism, Oxidation, and Inflammation in Mice. | 2018 | Details |
| A14568 | 29350678 | Exp Mol Med | PIK3R3 regulates PPARα expression to stimulate fatty acid β-oxidation and decrease hepatosteatosis. | 2018 | Details |
| A14569 | 29350612 | Microsc Microanal | The Effects of Betaine on the Nuclear Fractal Dimension, Chromatin Texture, and Proliferative Activity in Hepatocytes in Mouse Model of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14570 | 29349944 | J Korean Med Sci | Investigation of Clinical and Pathological Relationships between Adult- and Pediatric-type NASH in Korean Children. | 2018 | Details |
| A14571 | 29348947 | Case Rep Endocrinol | Effects of Mifepristone on Nonalcoholic Fatty Liver Disease in a Patient with a Cortisol-Secreting Adrenal Adenoma. | 2017 | Details |
| A14572 | 29348746 | Gastroenterol Res Pract | Impact of Time-Restricted Feeding and Dawn-to-Sunset Fasting on Circadian Rhythm, Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14573 | 29348103 | Pak J Pharm Sci | Prevalence of non alcoholic fatty liver and Non alcoholic Steatohepatitis in Peshawar Cantonment, Khyber Pakhtunkhwa, Pakistan. | 2018 | Details |
| A14574 | 29345914 | J Agric Food Chem | Comparative Analysis of EPA/DHA-PL Forage and Liposomes in Orotic Acid-Induced Nonalcoholic Fatty Liver Rats and Their Related Mechanisms. | 2018 | Details |
| A14575 | 29345253 | Acta Pharmacol Sin | 3-Acetyl-oleanolic acid ameliorates non-alcoholic fatty liver disease in high fat diet-treated rats by activating AMPK-related pathways. | 2018 | Details |
| A14576 | 29344336 | Ther Adv Endocrinol Metab | Treating nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a review of efficacy and safety. | 2017 | Details |
| A14577 | 29343420 | EBioMedicine | AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development. | 2018 | Details |
| A14578 | 29342916 | Nutrients | Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area. | 2018 | Details |
| A14579 | 29342182 | PLoS One | Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease. | 2018 | Details |
| A14580 | 29342107 | Molecules | Honokiol Improves Liver Steatosis in Ovariectomized Mice. | 2018 | Details |
| A14581 | 29341352 | J Biochem Mol Toxicol | Misregulation of membrane trafficking processes in human nonalcoholic steatohepatitis. | 2018 | Details |
| A14582 | 29341349 | Pathol Int | Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease. | 2018 | Details |
| A14583 | 29341046 | Horm Metab Res | Reduced Growth Hormone Secretion is Associated with Nonalcoholic Fatty Liver Disease in Obese Children. | 2018 | Details |
| A14584 | 29339098 | EBioMedicine | Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis. | 2018 | Details |
| A14585 | 29338271 | Rev Esp Enferm Dig | Analytical, anthropometric and dietary factors associated with the development of fibrosis in patients with nonalcoholic fatty liver disease. | 2018 | Details |
| A14586 | 29337849 | Antioxidants (Basel) | Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth? | 2018 | Details |
| A14587 | 29337015 | Chem Phys Lipids | Improved quantitative fatty acid values with correction of T2 relaxation time in terminal methyl group: In vivo proton magnetic resonance spectroscopy at ultra high field in hepatic steatosis. | 2018 | Details |
| A14588 | 29336868 | Eur J Intern Med | The therapeutic potential of targeting the peripheral endocannabinoid/CB1 receptor system. | 2018 | Details |
| A14589 | 29336468 | Int J Mol Med | Increased expression of sterol regulatory element binding protein‑2 alleviates autophagic dysfunction in NAFLD. | 2018 | Details |
| A14590 | 29335916 | Sleep Breath | Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2018 | Details |
| A14591 | 29335857 | Chin J Integr Med | Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats. | 2018 | Details |
| A14592 | 29335425 | Sci Rep | SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease. | 2018 | Details |
| A14593 | 29334960 | Environ Health | Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014. | 2018 | Details |
| A14594 | 29334743 | Vnitr Lek | [Adiponectin in patients with metabolic syndrome and diseases of the liver, bile ducts and pancreas]. | 2018 | Details |
| A14595 | 29333665 | Aliment Pharmacol Ther | Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis. | 2018 | Details |
| A14596 | 29333610 | Aliment Pharmacol Ther | Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative. | 2018 | Details |
| A14597 | 29331496 | J Nutr Biochem | Maternal betaine supplementation attenuates glucocorticoid-induced hepatic lipid accumulation through epigenetic modification in adult offspring rats. | 2017 | Details |
| A14598 | 29331340 | J Hepatol | Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signaling. | 2018 | Details |
| A14599 | 29330836 | Hepatol Int | Pathogenesis of non-alcoholic fatty liver disease mediated by YAP. | 2018 | Details |
| A14600 | 29330220 | Drug Metab Dispos | Regulation of Drug Metabolism by the Interplay of Inflammatory Signaling, Steatosis, and Xeno-Sensing Receptors in HepaRG Cells. | 2018 | Details |
| A14601 | 29329924 | Nutr Metab Cardiovasc Dis | Effects of dark chocolate on endothelial function in patients with non-alcoholic steatohepatitis. | 2017 | Details |
| A14602 | 29328556 | Liver Transpl | Coronary artery disease in decompensated patients undergoing liver transplantation evaluation. | 2018 | Details |
| A14603 | 29328026 | Georgian Med News | CLINICAL EFFICACY OF S-ADENOSYLMETHIONINE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS AND CHRONIC KIDNEY DISEASE I-II STAGE. | 2017 | Details |
| A14604 | 29327118 | Sleep Breath | Effect of CPAP therapy on liver disease in patients with OSA: a review. | 2018 | Details |
| A14605 | 29327078 | Cell Mol Life Sci | The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker? | 2018 | Details |
| A14606 | 29326657 | Front Endocrinol (Lausanne) | Early Microbes Modify Immune System Development and Metabolic Homeostasis-The "Restaurant" Hypothesis Revisited. | 2017 | Details |
| A14607 | 29326427 | Lab Invest | Severe steatosis induces portal hypertension by systemic arterial hyporeactivity and hepatic vasoconstrictor hyperreactivity in rats. | 2018 | Details |
| A14608 | 29325301 | Zhonghua Gan Zang Bing Za Zhi | [Role of CD36 in nonalcoholic fatty liver disease]. | 2017 | Details |
| A14609 | 29325294 | Zhonghua Gan Zang Bing Za Zhi | [Effects of Lactobacillus paracasei N1115 combined with fructooligosaccharides on non-alcoholic fatty liver disease induced by high-fat diet in mice]. | 2017 | Details |